Prochlorperazine is not a controlled substance. It does not appear on any of the five schedules of the U.S. Controlled Substances Act, and the Drug Enforcement Administration (DEA) does not regulate it. You still need a prescription to get it in the United States, but it faces none of the extra restrictions that apply to controlled drugs like opioids or benzodiazepines.
Why It Is Not Scheduled
The DEA places drugs on its controlled substances list when they carry a significant risk of abuse or dependence. Prochlorperazine belongs to a class of medications called phenothiazines, which work by blocking dopamine activity in a part of the brain that triggers nausea and vomiting. It also blocks certain adrenaline receptors and has mild anticholinergic effects. None of these actions produce the euphoria or reward that drives drug abuse, so it has never met the criteria for scheduling.
That said, stopping prochlorperazine abruptly after regular use can cause withdrawal symptoms like nausea, vomiting, dizziness, and shakiness. This reflects physical adaptation, not the kind of compulsive drug-seeking behavior the scheduling system targets. If you need to stop taking it, tapering gradually under a doctor’s guidance prevents these rebound effects.
How Prescriptions Differ From Controlled Drugs
Because prochlorperazine is a standard prescription medication rather than a controlled substance, several practical differences apply at the pharmacy:
- Refills. Federal law caps Schedule III and IV controlled substances at five refills within six months of the original prescription date. Prochlorperazine has no such federal limit. Your doctor can authorize refills according to their clinical judgment and your state’s pharmacy laws.
- Prescribing method. Controlled substances in Schedules II through V often require specific prescription formats, electronic prescribing systems, or in some states a special prescriber ID number. Prochlorperazine can be prescribed through a standard prescription.
- Monitoring. Many states track controlled substance prescriptions through prescription drug monitoring programs (PDMPs). Prochlorperazine is not tracked in these databases.
Status Outside the United States
Prochlorperazine is also uncontrolled in the United Kingdom, where it does not appear on the list of substances regulated under the Misuse of Drugs Act 1971. In fact, low-dose prochlorperazine tablets are available over the counter in UK pharmacies for short-term treatment of nausea and vomiting, without a prescription at all. In most countries, the drug is treated as a standard prescription or pharmacy-only medication rather than a controlled one.
What Prochlorperazine Is Used For
The FDA has approved prochlorperazine for three uses: controlling severe nausea and vomiting, treating schizophrenia, and short-term management of generalized non-psychotic anxiety. In practice, it is prescribed most often as an anti-nausea medication, particularly for migraines, vertigo, and post-surgical nausea.
For nausea, the typical oral dose is 5 to 10 mg taken three or four times a day, with a ceiling of 40 mg daily in most cases. When used for anxiety, the maximum is lower (20 mg per day), and treatment is limited to 12 weeks. For schizophrenia, doses can range much higher, up to 100 to 150 mg daily in severe cases under close supervision.
Side Effects Worth Knowing About
Even though prochlorperazine is not a controlled substance, it is not a casual medication. Its most notable risks involve involuntary movement disorders. Short-term use can cause muscle stiffness, restlessness, tremors, or sudden spasms of the face and neck. These reactions are more common at higher doses and in younger patients, and they usually resolve once the drug is stopped or the dose is lowered.
Long-term use carries a risk of tardive dyskinesia, a condition involving repetitive, involuntary movements of the tongue, lips, or face that can become permanent even after the medication is discontinued. This risk is one reason prochlorperazine is generally reserved for short-term use when prescribed for nausea or anxiety, and why ongoing monitoring matters for people taking it over longer periods for psychiatric conditions.